News

06/23/2023

Cupron® Introduces Revolutionary, Cost-effective Antimicrobial Technology, Cupron Sinerji™

Cupron®, a renowned antimicrobial solutions provider – doing business as Cupron Performance Additives – is excited to announce the significant expansion of its offerings with the introduction of Cupron Sinerji™. This new adjuvant-enhanced platform offers superior antimicrobial efficacy across multiple substrates, all while maintaining an economical cost structure. Cupron Sinerji incorporates adjuvants into the copper-based

06/21/2023

Children’s National Hospital Receives $96 Million Investment for Rare Pediatric Brain Tumor Research & Care

Children’s National Hospital announced a $96 million investment from an anonymous donor family that strengthens its globally recognized leadership to transform rare childhood brain tumor research and care. It is one of the largest donations in the hospital’s history. It allows Children’s National to recruit more top talent and advance the most promising research for

06/20/2023

Luminoah closes $6M Series A round

Charlottesville medical device company Luminoah Inc. has closed a $6 million Series A round it says it will use to complete the development of its mobile feeding tube device that collects data. The round was led by Charlottesville’s Fry’s Path Capital and included participation from Arlington’s Sands Capital, Charlottesville’s CAV Angels, Virginia Beach’s 757 Angels

06/09/2023

Apply Now: 📣 BLUE KNIGHT ™️ Resident QuickFire Challenge: Accelerating Project NextGen

Johnson & Johnson Innovation, together with the Biomedical Advanced Research and Development Authority (BARDA), is proud to launch the BLUE KNIGHT™ Resident QuickFire Challenge: Accelerating Project NextGen. Current and alumni Blue Knight residents and their collaborators are invited to submit promising potential pre-clinical or clinical solutions for the opportunity to receive award funding from a

06/08/2023

New Report Explores Latest Best Practices in State Bioscience Economic Development Initiatives

The Biotechnology Innovation Organization (BIO), in partnership with the Council of State Bioscience Associations (CSBA), released a new report on the best practices in state bioscience economic development measures, “The U.S. Biosciences Industry in the States: Best Practices in Innovation, Partnerships, and Job Creation.” The report, now in its seventh edition, analyzes the latest legislative

06/06/2023

CELLF BIO Achieves Milestone With First In Human Implantation of BioSphincter™

CELLF BIO achieved a major milestone with the world’s first human implantation of BioSphincter™, an autologous bioengineered sphincter made of smooth muscle and differentiated neural stem cells. The Phase 1 clinical trial is being conducted to treat patients with fecal incontinence (FI), a condition that affects millions of people worldwide. The implantation surgery was performed

06/05/2023

Activation Capital Announces Plans for Development of Innovation Center – A New Life Sciences Center at Bio+Tech Park

Activation Capital, an innovation ecosystem development organization, announced plans to develop the 102,000-square foot Innovation Center in the Bio+Tech Park in Richmond, Virginia. The 34-acre Bio+Tech Park is a commercial life sciences hub in downtown Richmond adjacent to the VCU Medical Center at Virginia Commonwealth University, and is home to over 70 companies, research institutes,

06/01/2023

ReAlta Life Sciences Announces Proof of Mechanism Data from the Phase 1b Inhaled LPS Trial of RLS-0071, Demonstrating Powerful Inhibition of Lung Neutrophils and Inflammatory Cytokines

ReAlta Life Sciences (“ReAlta”), Inc., a company addressing life-threatening rare diseases through harnessing the power of the immune system, today announced exciting new proof-of-mechanism data from the company’s Phase 1b Inhaled LPS clinical trial of RLS-0071 presented at the American Thoracic Society International Conference on May 23, 2023. RLS-0071 is the Company’s lead dual action

05/31/2023

Apply Now: BLUE KNIGHT™ QuickPitch: Activating for the Future

Recent global disease outbreaks have had devastating impacts, triggering a renewed emphasis on preparation for potential known and unknown health threats. By proactively enhancing preparedness against emerging pathogens, we aim to minimize the scale of future outbreaks, protect vulnerable populations, and ultimately safeguard our health security. To that end, Johnson & Johnson Innovation, together with

05/25/2023

Unintended consequences – FODMAP rich diets and digestive distress

Consumers are increasingly in pursuit of healthier diets, including plant-based diets, Mediterranean style diets and ones high in fiber. Along with these diet changes, though, can come digestive distress from specific dietary elements called FODMAPs (fermentable oligo-, di-, monosaccharides and polyols). FODMAPs can include lactose, found in dairy products; galactans, found in legumes; and fructans,

05/24/2023

Regional Partners Collaborate to Launch Advancing Oncology InnoVAtion QuickFire Challenge

Johnson & Johnson Innovation, in collaboration with Carilion Clinic Innovation, Verge Alliance, and Virginia Tech Corporate Research Center, is proud to launch the Advancing Oncology InnoVAtion QuickFire Challenge. Innovators from around the globe are invited to submit potential solutions aiming to transform patient outcomes in oncology in adult populations with potential applications in pediatric oncology.

05/23/2023

Eskandarian named dean of the VCU College of Engineering

Azim Eskandarian, D.Sc., has been named dean and William H. Goodwin Jr. Endowed Chair of the VCU College of Engineering, effective Aug. 1. Eskandarian currently serves as department head and Nicholas and Rebecca des Champs Professor of Mechanical Engineering in the College of Engineering at Virginia Tech. “Azim Eskandarian has established himself as a highly

05/23/2023

NSF Awards NOVA’s Biotechnology Program $550,000 for NOBLE Project

The NOVA Biotechnology and Leadership in Education (NOBLE) Project will be funded by the National Science Foundation with more than $550,000 over the next three years. The goal of the NOBLE Project is to revitalize and grow the biotechnology program. The NOBLE Project seeks to recruit students throughout the entire NOVA service area, particularly minorities

05/18/2023

Virginia Catalyst announces Grant Round 14 awarded projects

The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it has awarded $2 million in grants to four life and bioscience projects in the Commonwealth of Virginia, pending execution of the grant agreements. These grants, which will be met with significant matching funds from partner companies, were awarded

05/17/2023

Carilion Clinic promotes COO Arner to president

Nancy Agee remains CEO of Roanoke health care system Roanoke, VA /Virginia Business/ Carilion Clinic has promoted its executive vice president and chief operating officer, Steve Arner, to president of the Roanoke-based nonprofit health system. He will remain COO while taking on new duties as president, Carilion said in its announcement Tuesday. Nancy Howell Agee,

05/15/2023

Revivicor Building New R&D hub in SWVA

The company behind a pig-to-human heart transplant in 2022 is building a new research and development hub in Southwest Virginia to raise pigs for their hearts and kidneys, for transplantation into people. In March 2022, the first person to receive a heart transplant from a pig died, two months after the groundbreaking surgery at the

05/10/2023

LifeNet Health acquires best-in-class wound care portfolio

LifeNet Health expands its portfolio of wound care solutions, adding revolutionary products such as TheraSkin®, with the acquisition of the Bioventus Inc. wound care division. This step strengthens LifeNet Health’s position as a global leader in regenerative medicine offering next-level wound care. “Non-healing wounds are a modern healthcare crisis,” said LifeNet Health President and CEO

05/05/2023

Agrospheres to invest $25M in Albemarle expansion

Agricultural biotech startup AgroSpheres will invest $25 million to expand in Albemarle County, creating an estimated 50 jobs, Gov. Glenn Youngkin announced Thursday. The company will increase production at its facility at 1180 Seminole Trail and build a research and development and demonstration facility for new products, which will be a pilot plant for a

04/25/2023

VWCC and Radford Announce Agreement for Biotechnology Students

Virginia Western Community College and Radford University will sign an articulation agreement during a signing ceremony on Monday, May 1, on Virginia Western Campus, that will result in a cost-effective transition for students focusing on the field of biotechnology. Virginia Western students completing the Associate of Science (A.S.) degree in Science with a specialization in

04/25/2023

Biggest Risk Factors for Emerging and Mid-market Biopharma Companies, Costly Clinical Trial Delays

Aspirin, the original wonder drug, and its use as an analgesic and fever reducer can be traced back to 500 BC. Over the decades of the 20th and 21st centuries, the U.S. Food and Drug Administration (FDA) has approved the use of aspirin to manage and treat several health conditions, including in the prevention of

04/24/2023

Renewable Chemical Innovator Capra Biosciences to Build a Green Biochemical Production Facility in Manassas, Virginia

Capra Biosciences is scaling up their novel bioreactor technology to produce sustainable chemicals in Northern Virginia. This project was funded through a special BioMADE Project Call focused on advancing bioreactor design and development, thanks to support from Schmidt Futures. The expansion will jump start Virginia’s bioeconomy and place the state on the map for biochemical

04/20/2023

Mason engineers and partners receive $3M award to build new technology for personalized musculoskeletal injury rehabilitation to support troop readiness

Musculoskeletal injury (MSKI) is the most common form of medical injury experienced by Service members. Clinical interventions for MSKIs lack objective measures to determine their effectiveness, putting affected military personnel at risk of further damage if they return to duty  before fully recovering. George Mason University bioengineer Dr. Parag Chitnis, an associate professor in the

04/18/2023

VIPC Awards Commonwealth Commercialization Fund Grant to Carilion Medical Center

The Virginia Innovation Partnership Corporation (VIPC) announced that Carilion Medical Center has been awarded a Commonwealth Commercialization Fund (CCF) grant for $75,000. VIPC’s CCF programs have distributed over $47 million to Virginia-based startups, entrepreneurs and university-based inventors since 2012. Carilion Medical Center is a non-profit healthcare organization based in Roanoke, Va. The principal investigator for

04/13/2023

Lighthouse Labs names new managing director

Lighthouse Labs has announced Art Espey as the new Managing Director, effective April 17. Art will replace outgoing Managing Director Paul Nolde, who will assume a similar role at Norfolk’s 757 Collab and 757 Angels organizations. Art has long been involved with Lighthouse Labs, having previously served on the organization’s Board of Directors as Founding